secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biohaven Ltd. (BHVN)
CIK:        0001935979
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001628280-22-025893
Event type: other_material
Sentiment:  neutral
Materiality: 0.90
Item codes: 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biohaven Ltd. completes spin-off from RemainCo, appoints CFO and board
----------------------------------------------------------------------

- Spin-off effective Oct 3, 2022; shareholders received 1 Biohaven share per 2 RemainCo shares; 35,832,557 shares issued.
- Matthew Buten appointed CFO effective Sept 28, 2022.
- Board of directors named: Class I (Antonijevic, Heffernan, Hugin), Class II (Bailey, Childs, Gregory), Class III (Coric, Mehta).
- Adopted 2022 Equity Incentive Plan, Employee Share Purchase Plan, and Legacy Award Settlement Plan.
- Entered transition services, US distribution (Nurtec ODT) and outsourcing agreements with RemainCo and Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/biohavenltd8-k1032022.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-025893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer